From Lab to Assembly Line: Neuralink Targets Mass Production of BCIs

Neuralink is undergoing a fundamental transition from a research-oriented neurotechnology startup to a high-volume medical device manufacturer. Following the successful initial human implantations in the PRIME Study throughout 2024 and 2025, the company has pivoted toward scaling its infrastructure. This shift is centered on the construction of a major manufacturing hub in Austin, Texas, and the refinement of the R1 surgical robot, which is designed to automate the complex process of electrod...